We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Police are hunting four men who smashed their way into a jewellers in broad daylight and threatened staff with sledgehammers.
ComRes polling agency chairman says the next 100 days will be be gruelling in the most uncertain General Election that anyone can remember.
Pictures taken 70 years after the liberation of the Nazis' Auschwitz death camp echo the horrors of its Holocaust past.